Abstract
Protein homeostasis (proteostasis) is one of the nodal points that need to be preserved to retain physiologic cellular/organismal balance. The ubiquitin-proteasome system (UPS) is responsible for the removal of both normal and damaged proteins, with the proteasome being the downstream effector. The proteasome is the major cellular protease with progressive impairment of function during aging and senescence. Despite the documented age-retarding properties of proteasome activation in various cellular models, simultaneous enhancement of the 20S core proteasome content, assembly, and function have never been reported in any multicellular organism. Consequently, the possible effects of the core proteasome modulation on organismal life span are elusive. In this study, we have achieved activation of the 20S proteasome at organismal level. We demonstrate enhancement of proteasome levels, assembly, and activity in the nematode Caenorhabditis elegans, resulting in life span extension and increased resistance to stress. We also provide evidence that the observed life span extension is dependent on the transcriptional activity of Dauer formation abnormal/Forkhead box class O (DAF-16/FOXO), skinhead-1 (SKN-1), and heat shock factor-1 (HSF-1) factors through regulation of downstream longevity genes. We further show that the reported beneficial effects are not ubiquitous but they are dependent on the genetic context. Finally, we provide evidence that proteasome core activation might be a potential strategy to minimize protein homeostasis deficiencies underlying aggregation-related diseases, such as Alzheimer’s disease (AD) or Huntington’s disease (HD). In summary, this is the first report demonstrating that 20S core proteasome up-regulation in terms of both content and activity is feasible in a multicellular eukaryotic organism and that in turn this modulation promotes extension of organismal health span and life span.—Chondrogianni, N., Georgila, K., Kourtis, N., Tavernarakis, N., Gonos, E. S. 20S proteasome activation promotes life span extension andresistance to proteotoxicity in Caenorhabditis elegans.
Keywords: aging, daf-16, longevity, proteostasis
Aging is an inevitable natural biologic process that is defined as the time-dependent functional decline of organismal homeostasis accompanied, among others, by increased levels of damaged macromolecules (1, 2). Protein homeostasis (proteostasis) is a major node that needs to be preserved to retain organismal homeostasis (3). Recently, loss of proteostasis has been included among the hallmarks of aging (4) because chronic proteostasis imbalance exerts a direct negative impact on cellular and organismal life span (5). The various proteolytic networks are the ultimate arsenal ensuring intracellular proteostasis by eliminating damaged proteins.
The UPS is the primary site for controlled protein degradation. Specifically, normal but also abnormal, denatured, or otherwise damaged proteins are degraded by the proteasome. The 20S core proteasome is a cylinder composed of 7 different α- and 7 different β-subunits, arranged as a α1–7β1–7β1–7α1–7 structure. Three of the β-catalytic subunits (β1, β2, and β5) are the enzymatic centers of the proteasome activities with chymotrypsin-like (CT-L) activity (exerted by β5) being the major one. Attachment of 1 or 2 19S regulatory complexes at the end of the 20S core give rise to the 26S proteasome that degrades polyubiquitinated proteins in an ATP-driven process (6).
Progressive impairment of proteasome function during aging and cellular senescence is well documented (7–9), and proteasome activation has been proposed as a putative antiaging strategy (10). So far, only enhancement of the 26S proteasome activity but not increase of the overall proteasome content has been achieved through the overexpression of components of the internal proteasome activator, namely the 19S complex (11, 12). However, it remains elusive whether enhancement of both proteasome content and activity/function is feasible in a multicellular organism and if such modulation has an effect on the organismal life span. We demonstrate, for the first time genetically mediated 20S core proteasome content up-regulation and activation in a multicellular organism, namely Caenorhabditis elegans, through the overexpression of the pbs-5 20S subunit (ortholog of the human β5 subunit), and we provide evidence on the role of proteasome enhancement in the determination of organismal life span, stress resistance, and aggregation-related pathologies.
MATERIALS AND METHODS
Strains and genetics
We followed standard procedures for C. elegans strain maintenance at 20°C, unless otherwise indicated. The following strains were used: N2 [wild-type Bristol isolate (wt)], CB1370: daf-2(e1370)III, DR26: daf-16(m26)I, DR1309: daf-16(m26)I;daf-2(e1370)III, PS3551: hsf-1(sy441)I, CF1553: muIs84[pAD76(sod-3::GFP)], CF1139: daf-16(mu86)I;Is[pdaf-16DAF-16a::GFP], AM140: rmIs132[punc-54(Q35::YFP)], AM101: rmIs110 [pF25B3.3(Q40::YFP)], CL4176: dvIs27[pAF29(myo-3/A-Beta1-42/letUTR)+pRF4(rol-6(su1006))]. The following strains carrying extrachromosomal arrays were used: N2Ex[plet-858PBS-5], daf-2(e1370)Ex[plet-858PBS-5], daf-16(m26)Ex[plet-858PBS-5], daf-16(m26);daf-2(e1370)Ex[plet-858PBS-5], hsf-1(sy441)Ex[plet-858PBS-5], muIs84[pAD76(psod-3GFP)]Ex[plet-858PBS-5], daf-16(mu86)I;Is[pdaf-16DAF-16a::GFP] Ex[plet-858PBS-5]Ex[plet-858PBS-5], rmIs132[punc-54(Q35::YFP)]Ex[plet-858PBS-5], rmIs110 [pF25B3.3(Q40::YFP)]Ex[plet-858PBS-5] and dvIs27[pAF29(myo-3/A-Beta1-42/letUTR)+pRF4(rol-6(su1006))]Ex[plet-858PBS-5].
Molecular cloning
The pbs-5 ORF plus 409 bp of 3′-UTR was PCR-amplified from genomic DNA using the 5′-ACCGGTATGTGGGGCGAGACATTCG -3′ and 5′-GGGCCCACGTCATCAACACCCAGCC-3′ primers, carrying the AgeI/ApaI restriction sites and cloned into the L2865 vector. The construct was coinjected into the gonads of animals together with pRF4 plasmid carrying the rol-6(su1006) dominant transformation marker or a plasmid carrying the reporter gene punc-122GFP, which tags the nematode coelomocytes. Several transgenic lines were obtained and analyzed for pbs-5 expression. Data are presented for wt line 1; pbs-5 overexpression (pbs-5 OE). Control worms were injected only with the coinjection marker.
Life span analysis
Synchronized young adult animals were transferred to fresh plates (100–200 individuals per experiment). D 1 of adulthood was set as t = 0. Animals were transferred to fresh plates every 2–3 d and examined every d for touch-provoked movement and pharyngeal pumping until death. Each survival assay was repeated at least twice. Representative assays are shown in figures; statistics refer to all performed assays. Survival curves were created using the product-limit method by Kaplan and Meier. The percentage of nematodes remaining alive is plotted against animal age. The log-rank (Mantel-Cox) test was used to evaluate differences between survival curves and to determine P values for all independent data. N in life span figures is the number of animals that died over total where total equals the animals number that died plus the number of censored animals (due to internally hatched eggs, extruded gonad, or desiccation due to crawling off the plates). Median life span values are expressed as mean ± sem.
Oxidative stress resistance assays
Nematodes at L4 stage were exposed to 2 mM paraquat, and survival was scored on d 5 [for wt and daf-16(m26)] and on d 10 [for daf-2(e1370)] of exposure. Nematodes at d 1 of adulthood were exposed to freshly made 80 mM juglone for 45 min at 20°C and survival was scored after 24 h recovery.
Heat stress resistance assays
Synchronized animals were grown at 20°C until d 1 of adulthood. Worms were then transferred at 35°C for 8 h and scored for survival after 24 h recovery at 20°C. Nematodes were scored as dead if they failed to respond to heat or tactile stimuli.
RNA isolation and real-time PCR analysis
RNA was extracted from synchronized young adult animals and analyzed by standard methods. Primers are summarized in Table 1. Data were analyzed using the comparative 2−ΔΔCt method and are presented as the x-fold difference in mRNA transcript abundance in transgenic or RNA interference (RNAi)-subjected animals, normalized to the endogenous pmp-3 gene, relative to control animals. Use of cdc-42 as normalizer produced similar results. Both genes were validated for quantitative gene expression studies using the GeNorm application, in agreement with previous studies (13).
TABLE 1.
Primers used for real-time PCR analysis
Gene | Forward primer (5′ → 3′) | Reverse primer (5′ → 3′) |
---|---|---|
pbs-1 | TGTGCCGTTCTGGATCTG | TGTAGAGGAATTGGCGGA |
pbs-2 | GCCCACATCTTTATATGTGCTC | TCTCGGCTTCATCTTTCGT |
pbs-5 | CCACTTATCGGGATTCTGG | GGCAAACTCGTACCACAG |
pas-2 | GGAATACGAAATGATGTACGG | CGAACACCACCAGATTGAG |
pas-5 | GCATTGGAATCAAGACGAG | GAGTCGGCAATCAAACCT |
rpn-6 | GATGGAGATATTAAGGTTGGAC | TCATTATAGAGGCGAACAAGAC |
rpn-11 | TACTCCATCCCAATCGCC | TGCTCCTTGTTCTGTTCAC |
rpt-5 | GCAGTCATTAAGACTTCCACTC | ATCCTTATTGACACCAACGA |
rpt-6 | GGTTCCTGATTCAACATACGA | TCCAAAGAGCAAGACTCCT |
gst-4 | AAGTTGTTGAACCAGCCC | AATCACAATATCAGCCCAAGTC |
sod-3 | GCAGATTTGGAACCTGTAAT | AGCCTCGTGAAGTTTCTC |
daf-16 | GCACAAGTTTACGAATGGA | CGAGAATGAAGAGACAGATTG |
skn-1 | GAGACGAGACGATAAACGA | CAGATGAATATGGACGACACTC |
hsp-16.2 | CTTTACCACTATTTCCGTCCA | TAACAATCTCAGAAGACTCAGA |
pmp-3 | GTTCCCGTGTTCATCACTCAT | ACACCGTCGAGAAGCTGTAGA |
cdc-42 | CTGCTGGACAGGAAGATTACG | CTCGGACATTCTCGAATGAAG |
RNA interference
The pbs-5 RNAi construct is from the Ahringer library (14) (Source Bioscience LifeSciences, Nottingham, United Kingdom). Synchronized young adult animals (120 individuals per experiment) were transferred on NGM plates seeded with HT115(DE3) bacteria transformed with either the empty pL4440 vector or the RNAi-encoding plasmid. Isopropyl-β-d-1-thiogalactopyranoside (2 mM) induced the double-stranded RNA expression.
Immunoblot analysis and detection of oxidized proteins
Synchronized young adult animals (unless otherwise stated) were collected and boiled in nonreducing Laemmli buffer (NRLB) for 10 min. SDS-PAGE and immunoblotting was performed as described previously (8). Actin was used as a loading control (MP Biomedicals, Santa Ana, CA, USA; clone C4). Immunoblot detection of carbonyl groups into proteins (oxidized proteins) was performed with Oxyblot protein oxidation kit (Chemicon International, Temecula, CA, USA). Each immunoblot was repeated at least twice. Quantification of the ratio of each detected protein to actin and normalization to control appear under each representative immunoblot.
Dot blot Analysis
Equal numbers of synchronized animals were collected 24 h after temperature upshift from 16 to 25°C, washed, resuspended, and homogenized in M9 using ultrasounds. The proteins were precipitated with methanol/chloroform (3:1/vol:vol) and resuspended in NRLB. The same volume of total protein was spotted onto 0.2 μm nitrocellulose membrane. Immunoblotting was performed using 6E10 antibody (Covance, Madison, WI, USA; recognizes total Aβ protein species) or an anti-amyloid oligomer antibody (Rbx; Merck Millipore, Darmstadt, Germany; recognizes all kinds of amyloid oligomers). Part of the lysates was subjected to SDS-PAGE, and actin was used as a loading control. Each dot blot was repeated at least twice. Quantification of the ratio of each detected protein to actin and normalization to control appear under each representative dot blot.
Proteasome peptidase assay
Synchronized young adult animals were homogenized in proteasome activity lysis buffer (1 M Tris-HCl, pH 7.6, 100 mM ATP, 3 M KCl, 0.1 M EDTA, 1 M DTT, 0.2% Nonidet P-40, 10% glycerol, 10 μg/ml aprotinin, and 10 mM PMSF) using ultrasounds. CT-L activity was assayed with hydrolysis of the fluorogenic peptide LLVY-AMC (Enzo Life Sciences, Lausen, Switzerland), for 30 min at 37°C. Specific activity was determined in the presence of 20 μM MG132 or 20 μM lactacystin. Fluorescence was measured in a fluorescence spectrophotometer.
Native gel electrophoresis for proteasome complexes
Synchronized animals were collected, washed, resuspended in proteasome activity lysis buffer, and homogenized using ultrasounds. Protein (40 μg) was used for native gel electrophoresis for proteasome complexes followed by immunoblot analysis as described previously (15). Antibodies against selected 19S or 20S subunits were applied to detect 26S and 20S fully assembled proteasomes. Part of the lysates was subjected to SDS-PAGE, and actin was used as a loading control. Each blot was repeated at least twice. Quantification of the ratio of each detected proteasome complex to actin and normalization to control appear under each representative native gel.
Microscopy
Animals were mounted on 2% agarose pads, anesthetized with 5 mM sodium azide and observed at room temperature. Endogenous gut fluorescence and GFP levels were examined using a fluorescence Zeiss Axioplan 2 microscope (Carl Zeiss, Jena, Germany) with the Endow GFP filter (EX BP 470/40, BS FT 495, EM BP 525/50). Images were acquired using an Olympus DP71 Digital camera (Olympus, Tokyo, Japan) and Olympus CELL-A software. Emission intensity was measured on gray scale images with an 8 bit pixel depth (256 shades of gray). At least 30 images per condition from 3 independent trials were processed with the NIH ImageJ software (National Institutes of Health, Bethesda, MD, USA). For DAF-16a::GFP localization, synchronized control and pbs-5 OE animals, expressing the pdaf-16DAF-16a::GFP transgene reporter fusion in daf16(mu86) genetic background (CF1139), were grown at 20°C, mounted on 2% agarose pads, and immobilized with 5 mM levamisole. The localization of DAF-16a::GFP was examined at d 1 of adulthood. Worms were classified into 3 groups, according to the extent of nuclear-cytoplasmic GFP distribution in the intestinal cells.
Paralysis assay
Synchronized AM140 and the relative pbs-5 OE animals were grown at 20°C. Synchronized CL4176 and the relative pbs-5 OE animals were grown at 16°C for 2 d before temperature up-shift to 25°C for transgene induction. Paralysis scoring was initiated at d 1 of adulthood for AM140 and 16 h following temperature up-shift for CL4176. The percentage of paralyzed animals is plotted against animal age for AM140 strain and against the hours post-temperature up-shift for CL4176 strain. Nematodes were scored as paralyzed if they failed to move, exhibited “halos” of cleared bacteria around their heads, accumulated eggs close to their bodies, or failed to respond to a touch-provoked movement. Animals that died were excluded. The log-rank (Mantel-Cox) test was used to evaluate differences between paralysis curves and to determine P values for all independent data. N in paralysis figures is the number of animals that paralyzed over total where total equals the number of paralyzed animals plus the number of dead and censored. Median paralysis values are expressed as mean ± sem.
Motility assay
Animals were grown at 20°C until L4 stage and then transferred at 25°C. RNAi-treated strains were transferred at d 1 of adulthood to HT115-seeded plates, containing an empty control vector (pL4440) or expressing double-stranded RNAi of the pbs-5 gene. Motility of each animal (number of body circles) was monitored for 1 min at d 5.
Statistical analysis
Statistical analyses were performed using Prism (GraphPad Software Incorporated, La Jolla, CA, USA) and Microsoft Office 2003 Excel (Microsoft Corporation, Redmond, WA, USA) software packages. Mean values were compared using unpaired t tests. Data in all assays are the mean of 3 independent experiments, unless otherwise indicated.
RESULTS
Overexpression of pbs-5 catalytic proteasome subunit confers enhanced proteasome content, assembly, and activity
To assess whether enhancement of proteasome content and activity is possible in a multicellular organism, we initially established stable transgenic lines overexpressing the pbs-5 gene in wt C. elegans. pbs-5 is the ortholog of the human β5 subunit that is responsible for the main proteasome activity, namely CT-L activity, and has been shown to be the core rate-limiting subunit for proteasome activation in human primary fibroblasts (16). It is noteworthy that pbs-5 was the only 20S subunit that was found up-regulated in glp-1 mutants, which display increased proteasome activity (12). RNA expression analysis for pbs-1, pbs-2, pbs-5, pas-2, and pas-5 subunits (Fig. 1A) revealed up-regulation of both α- (pas)- and β- (pbs)-type subunits in pbs-5 OE animals. Protein expression analysis for PBS-1 and PBS-5 subunits (Fig. 1B) verified the overexpression of both subunits. The enhanced expression levels of proteasome subunits were also translated to increased functional proteasome levels, because we detected enhanced levels of CT-L activity by ∼1.8-fold in pbs-5 OE animals (Fig. 1C; the conditions used for the activity assay favored the detection of both 20S and 26S proteasome activity). Proteasome inhibitors (MG132 and lactacystin) blocked the activities in both extracts from control and pbs-5 OE animals, thus verifying the specificity of the measurements (Supplemental Fig. 1A). Enhanced proteasome activity was also detected in a second pbs-5 OE line (Supplemental Fig. 1B), thus eliminating a line-specific effect. Analysis of proteasome complexes revealed more 20S and 26S particles in pbs-5 OE animals (Fig. 1D) and lower polyubiquitinated protein levels (Fig. 1E). To exclude that rpn-6 overexpression is responsible for this activation as suggested by Vilchez et al. (12), we have also tested the protein expression levels of RPN-6 in pbs-5 OE animals that was not found up-regulated (Supplemental Fig. 1C). Overall, these results suggest that pbs-5 OE leads to increased proteasome content, assembly, and activity in C. elegans, by analogy to previous studies in human primary fibroblasts upon overexpression of the human β5 subunit (16). This is the first report for genetically mediated 20S core proteasome activation (in both terms of activity and content) in a multicellular organism.
Figure 1.
pbs-5 OE induces proteasome expression and function in wt C. elegans. A) Real-time PCR analysis of pbs-1, pbs-2, pbs-5, pas-2, and pas-5 subunits in wt control and pbs-5 OE animals. Expression levels of each gene were arbitrarily set to 1 in control animals. pmp-3 gene expression was used as normalizer. B) Immunoblot analysis of PBS-1 and PBS-5 subunits in wt control and pbs-5 OE animals. C) Proteasome activity in pbs-5 OE animals is expressed as percentage (%) with mean value of CT-L activity in control animals set to 100%. Native gel electrophoresis followed by immunoblot analysis against PBS-5 (20S subunit) and RPT-6 (19S subunit) (D) and immunoblot analysis of polyubiquitinated (Poly-Ub) proteins in wt control and pbs-5 OE animals (E). Actin was used as a loading control. Error bars denote ± sem. CP, core particle; RP, regulatory particle (single capped), RP2, regulatory particle (double capped). *P < 0.05, **P < 0.01, ***P < 0.001.
Proteasome activation extends the life span of wt animals
Proteasome function has been shown to decline during aging and senescence of different cells, tissues, and organisms (3) and 20S core proteasome activation has been shown to extend cellular life span in human primary fibroblasts (16). We therefore sought to determine whether 20S activation affects C. elegans longevity. Life span analysis showed that pbs-5 OE resulted in significant extension of animal life span (Fig. 2A; results were confirmed in a second line, Supplemental Fig. 2A). Immunoblot analysis of PBS-5 in d 5 verified that pbs-5 OE is maintained during animal life span (Supplemental Fig. 1D). In support, knock-down of pbs-5 by RNAi (for RNA and protein analysis following RNAi, see Supplemental Fig. 3A and B) abolished the extended life span of pbs-5 OE animals (Supplemental Fig. 3C). Interestingly, knock-down of pbs-5 promoted an up-regulation in the expression of other 20S subunits, probably as a compensatory mechanism to the decreased levels of the crucial pbs-5 subunit (Supplemental Fig. 3D) in accordance with previous studies in C. elegans (12, 17) and Drosophila (18). We also examined whether the extended life span is coupled with physiologic and metabolic changes related to deceleration of the aging process. Despite valuable criticism regarding lipofuscin accumulation in aged C. elegans (19, 20), age pigment (intestinal lipofuscin and advanced glycation end-products) accumulation is a known feature of aging in various species that has been used as a reporter of nematode health span (21, 22). To this end, we found significantly lower levels of age pigment autofluorescence in pbs-5 OE compared with control animals at different time points (Fig. 2B, C). In conclusion, proteasome activation through pbs-5 OE results in wt animal life span extension and increased health span.
Figure 2.
pbs-5 OE extends the life span and health span of wt C. elegans. A) Survival curves of wt control and pbs-5 OE animals. Control: mean = 14.0 ± 0.4, n = 497/604, pbs-5 OE: mean = 17.7 ± 0.7, n = 546/620, P < 0.0001. B) Quantification of intestinal autofluorescence and (C) representative images of wt control and pbs-5 OE animals at d 5, 7, 10, and 15 of adulthood. Three independent experiments, 30 animals per strain per time point. Error bars denote ± sem. **P < 0.01, ***P < 0.001.
We also examined pbs-5 OE animals for phenotypic differences as these characteristics are altered in long-lived C. elegans mutants (feeding behaviors, fecundity, developmental abnormalities, movement defects, and anatomic alterations; Table 2). We did not observe any severe physiologic alterations between pbs-5 OE and control animals. Notably, we detected selected signs that have been causally linked with longevity of long-lived mutants (23, 24), such as slightly slower developmental timing and defecation rhythms and increased capacity to enter the stress-resistant dauer larvae form. These measurements suggest that although pbs-5 OE animals do not exhibit pronounced physiologic alterations, the observed differences contribute to life span extension.
TABLE 2.
Phenotypic analysis of wt pbs-5 OE animals
Animals | Pharyngeal pumpinga | Defecationb | Body sizec | Fecundityd | Embryonic lethalitye | Developmental timingf | Dauer formationg |
---|---|---|---|---|---|---|---|
Control | 222 ± 25 | 40 ± 3 | 1.2 ± 0.01 | 303 ± 21 | 0.2 ± 0.4 | 55 ± 1 | 1.0 ± 0.5 |
pbs-5 OE | 230 ± 15 | 49 ± 5* | 1.1 ± 0.01 | 366 ± 64* | 1.2 ± 1.3 | 57 ± 1* | 10.0 ± 6.2† |
All assays were performed at 20°C unless noted otherwise. aPumps per minute. bDuration of defecation cycle in seconds. cAdult body length in millimeters. dNumber of eggs laid per worm. ePercentage of eggs that failed to hatch. fDuration of postembryonic development (hours from egg hatching to L4 molt). gPercentage of animals that become dauer larvae at 27°C. *P < 0.001. †P < 0.05.
pbs-5 OE-mediated life span extension is dependent on the DAF-16/FOXO, SKN-1, and HSF-1 transcription factors
Aging in C. elegans is mainly regulated by the conserved endocrine insulin/IGF-1 signaling (IIS) pathway that involves the IGF receptor DAF-2 and DAF-16/FOXO transcription factor (25). First, we investigated whether pbs-5 OE might influence life span via DAF-16. pbs-5 OE further extended the life span of long-lived daf-2 mutants (Fig. 3A; results were confirmed in a second line, Supplemental Fig. 2B). However, this extension was abolished in the pbs-5 OE daf-16 mutants (Fig. 3B). Moreover, loss of DAF-16 fully suppressed the longevity conferred by pbs-5 OE in daf-2 mutants [daf-16(m26);daf-2(e1370); Fig. 3C]. These results suggest that pbs-5-mediated life span extension requires DAF-16 activity and DAF-16 acts downstream of PBS-5.
Figure 3.
pbs-5 OE-mediated life span extension is dependent on the DAF-16/FOXO transcription factor. Survival curves of control and pbs-5 OE (A) daf-2(e1370). Control: mean = 35.5 ± 0.5, n = 198/289, pbs-5 OE: mean = 42.5 ± 1.5, n = 205/313, P < 0.0001. B) daf-16(m26) (including wt control and pbs-5 OE animals values, which appear in Fig. 2). Control: mean = 13.2 ± 0.6, n = 421/554, pbs-5 OE: mean = 12.2 ± 0.2, n = 418/575, not significant (NS). C) daf-16(m26);daf-2(e1370). Control: mean = 18.0 ± 1.0, n = 216/259, pbs-5 OE: mean = 17.0 ± 0.0, n = 191/254, NS. D and E) Quantification of fluorescence intensity (D) and representative images (E) of control and pbs-5–overexpressing animals carrying the DAF-16/FOXO transcriptional reporter psod-3GFP at d 1, 3, and 5 of adulthood. Four independent experiments, 30 animals per strain. F) Percentage of cytosolic, nuclear, or intermediate accumulation of DAF-16a::GFP in control and pbs-5 OE animals, expressing the pdaf-16DAF-16a::GFP transgene reporter fusion in daf-16(mu86) genetic background. Six independent experiments, 150 animals per strain per time point. Error bars denote ± sem. ***P < 0.001.
To investigate whether DAF-16 transcriptional activity is modified upon pbs-5 OE, we monitored the expression of the reporter psod-3GFP in pbs-5–overexpressing animals. psod-3GFP is transcriptionally up-regulated in a DAF-16–dependent manner (26), and sod-3 is a usual reporter for DAF-16 activity (27, 28). We found that pbs-5 OE produced a significant increase in psod-3GFP expression in various tissues at all examined ages (Fig. 3D, E). Consistent with this observation, mRNA levels of endogenous sod-3 gene were markedly elevated in wt pbs-5 OE animals and pbs-5 OE daf-2 mutants, whereas sod-3 induction was lost in pbs-5 OE daf-16 mutants (Supplemental Fig. 4A). Moreover, pbs-5 knockdown abolished sod-3 induction in pbs-5 OE animals (Supplemental Fig. 4B). Finally, we neither recorded any changes of the endogenous daf-16 mRNA levels (Supplemental Fig. 4C) nor detected any significant changes in DAF-16 intracellular localization using a reporter fusion of DAF-16 (pdaf-16DAF-16a::GFP; Fig. 3F) upon pbs-5 OE. Therefore, we suggest that pbs-5 OE may affect DAF-16 function by promoting its nuclear activity but not its translocation. Such regulation has been previously shown for various DAF-16 regulators [i.e., HCF-1 (29), EAK-7 (30), and SMK-1 (31)]. Moreover, up-regulation of DAF-16 target survival genes, such as sod-3 could, at least in part, account for the pbs-5–mediated longevity.
The transcription factor skn-1 is also prominent in life span regulation (32, 33) and oxidative stress resistance (34), and it also responds to proteasome perturbations (17, 34–36). Therefore, we have also tested its levels and activity in pbs-5 OE animals. We did not detect changes of the endogenous skn-1 mRNA levels upon pbs-5 OE, implying that they are not affected per se by this overexpression (Supplemental Fig. 4D). Knock-down of skn-1 (for RNA analysis of skn-1 and its target gene gst-4 following skn-1 RNAi, see Supplemental Fig. 4E, F) in pbs-5 OE animals abolished their extended life span (Fig. 4A). This abolishment was not due to a direct, reduced transcription of proteasome subunits because the mRNA levels of different subunits were not significantly decreased in animals subjected to RNAi for skn-1 gene (Fig. 4B). The mRNA levels of gst-4 target gene were increased in pbs-5 OE animals, thus revealing enhanced SKN-1 transcriptional ability upon pbs-5 OE (Fig. 4C). These results imply that pbs-5–mediated life span extension also requires SKN-1 activity.
Figure 4.
pbs-5 OE-mediated life span extension is dependent on the SKN-1 and HSF-1 transcription factors. A) Survival curves of pbs-5 OE animals subjected to RNAi for skn-1 or the empty vector. Control (vector): mean = 19.5 ± 0.5, n = 123/148, skn-1(RNAi): mean = 16 ± 1.0, n = 134/151, P < 0.0001. Real-time PCR analysis of (B) pbs-1, pbs-2, and pbs-5 subunits and (C) gst-4 gene in (B) control animals subjected to RNAi for skn-1 or the empty vector and (C) wt control and pbs-5 OE animals. Expression levels of each gene were arbitrarily set to 1 in control animals. pmp-3 gene expression was used as normalizer. D) Survival curves of control and pbs-5 OE hsf-1(sy441) animals. Control: mean = 10.0 ± 0, n = 184/370, pbs-5 OE: mean = 9.0 ± 0, n = 103/390, P < 0.0001. E) Survival of control and pbs-5 OE hsf-1(sy441) animals subjected to HS. Six independent experiments, 700 animals per strain. Error bars denote ± sem. ***P < 0.001.
We also examined the requirement of the heat-shock transcription factor hsf-1, a key player of the proteostasis network, on pbs-5–mediated life span extension. We found that this extension is also dependent on HSF-1 (Fig. 4D); pbs-5 OE shortens the life span of hsf-1 mutants. Given that collapse of proteostasis is an early molecular event (37) and that protein aggregates can lead to global UPS impairment (38), we assume that the pbs-5–mediated proteasome activation remains insufficient in mutants with highly impaired proteostasis, such as hsf-1 mutants. Moreover, we have performed thermal stress in pbs-5–overexpressing hsf-1 mutants and we did not record any resistance (Fig. 4E). We also observed a significant down-regulation of hsp-16.2 (an hsf-1 target gene) mRNA levels in pbs-5 OE hsf-1 mutants, thus further advocating for the lack of resistance upon heat stress (HS; Supplemental Fig. 4G). Supportingly, PBS-5 was recently shown to be a negative heat shock response (HSR) regulator (39). Accordingly, pbs-5 OE in wt animals neither extended their life span under conditions of mild HS at 25°C (Supplemental Fig. 4H) nor conferred any resistance during acute heat stress at 35°C (Supplemental Fig. 4I). In total, these experiments suggest that pbs-5 OE-mediated life span extension is dependent on DAF-16/FOXO, SKN-1, and HSF-1 transcription factors.
Proteasome activation confers resistance to oxidative stress
Given that the proteasome is activated upon oxidative stress (40), we investigated the possible resistance of pbs-5 OE animals to different oxidants, namely paraquat and juglone. Paraquat is a generator of superoxide anions, whereas juglone is a reactive oxygen-generating naphthoquinone and a producer of damaging adducts with proteins. pbs-5 OE animals were significantly more resistant to both stressors (Fig. 5A). It has been shown before that carbonylated proteins, which are by-products of oxidative stress (41), can be degraded by the proteasome (42). We detected decreased levels of low to middle molecular weight carbonylated proteins (30 to 70 kDa) in pbs-5 OE animals (Fig. 5B). These decreased levels may be due to the enhanced levels of proteasome activity and, in turn, may contribute to the observed increased stress resistance.
Figure 5.
pbs-5 OE increases oxidative stress resistance in animals with intact DAF-16/FOXO transcription factor. A) Survival of wt control and pbs-5 OE animals treated with paraquat (3 independent experiments, 350 animals per strain) and juglone (8 independent experiments, 700 animals per strain). B) Oxyblot analysis of carbonylated proteins in wt control and pbs-5 OE young adult animals. MW markers containing 1-3 DNP residues/molecule are shown on the left. Actin was used as a loading control. Survival of control and pbs-5 OE (C) daf-2(e1370) and (D) daf-16(m26) animals treated with paraquat at d 10 and 5 of exposure, respectively; 350 animals per strain. Error bars denote ± sem. NS, not significant. **P < 0.01, ***P < 0.001.
To assess whether oxidative stress resistance is also dependent on DAF-16/FOXO factor, we exposed pbs-5-overexpressing daf-2 and daf-16 mutants to paraquat. pbs-5 OE daf-2 mutants were more resistant to oxidative stress (Fig. 5C), although this resistance was eliminated in pbs-5 OE daf-16 mutants (Fig. 5D). We conclude that DAF-16 factor is required for the increased oxidative stress resistance of pbs-5 OE animals.
Proteasome activation confers deceleration of aggregation-related pathologies and maintenance of proteostasis
Neurodegenerative disorders such as AD or HD are characterized by protein homeostasis perturbations and have been directly linked to proteasome malfunction (43, 44). Therefore, we tested the effects of pbs-5 OE in relation to these diseases. To this end, we exploited 2 nematode polyglutamine (polyQ) disease models, in which expression of polyQ protein in the body wall muscles (AM140 strain) (45) and in neurons (AM101 strain) (46) causes proteotoxic aggregation that results in age-dependent paralysis and motility defects. Remarkably, pbs-5 OE in animals expressing 35 glutamine residues (Q35) in body wall muscle delayed the observed paralysis (Fig. 6A; results were confirmed in a second line, Supplemental Fig. 2C) and significantly improved motility of worms expressing Q40 in neurons (Fig. 6B). Accordingly, RNAi of pbs-5 had a detrimental effect on animal motility (Fig. 6C). Likewise, in CL4176 strain (an AD model where human Aβ1-42 is expressed in a temperature-inducible manner in muscle thus leading to paralysis) (47), pbs-5 OE significantly delayed the paralysis phenotype (Fig. 6D; results were confirmed in a second line, Supplemental Fig. 2D). It has already been shown in another AD model (CL2006 strain) that increase of the Aβ oligomeric/toxic species follows Aβ expression in paralyzed worms (48). Notably, we revealed that total but also oligomeric Aβ levels were reduced in pbs-5 OE CL4176 animals as compared with the control animals (Fig. 6E, Supplemental Fig. 2E), presuming that this reduction is due to the elevated levels of proteasomal degradation of pbs-5 OE animals. In total, pbs-5 OE appears to protect against the aggregate-related pathology progression and polyQ or Aβ proteotoxicity.
Figure 6.
pbs-5 OE reduces polyglutamine and Aβ toxicity. A) Paralysis curves of control and pbs-5 OE animals, expressing Q35::YFP in body wall muscle cells (AM140 strain). Control: mean = 6 ± 0, n = 220/303, pbs-5 OE: mean = 7.5 ± 0.5, n = 135/292, P < 0.0001. Percent motility of (B) control and pbs-5 OE animals expressing Q40::YFP in neurons (AM101 strain), and (C) animals expressing Q40::YFP in neurons subjected to RNAi for pbs-5 or the empty vector at d 5 of adulthood. Mean value of motility of control animals set to 100%; 80 animals per strain. D) Paralysis curves of control and pbs-5 OE animals expressing human Aβ1-42 peptide (CL4176 strain), Control: mean = 25.67 ± 1.2, n = 485/491, pbs-5 OE: mean = 28 ± 2, n = 334/349, P < 0.0001. E) Dot blot analysis of total Aβ and Aβ oligomers in control and pbs-5 OE animals expressing human Aβ1–42 peptide (CL4176 strain) 24 h post-temperature up-shift. Equal numbers of worms were lysed and spotted for dot blot analysis or run in SDS-PAGE. Actin was used as a loading control. Error bars denote ± sem. ***P < 0.001.
DISCUSSION
Increasing evidence suggests that positive modulation of proteostasis-related key players, including proteolytic mechanisms like the UPS, confer high proteome protection and maintenance and contribute to the extended life span mediated by several pathways, such as IIS and dietary restriction (DR). This study demonstrates that overexpression of a single 20S core proteasome subunit, namely pbs-5, leads to enhancement of proteasome content and activity of both 20S and 26S complexes in a multicellular organism. This activation extends the life span of wt nematodes and confers resistance to oxidative stress. Our findings suggest that these ameliorated characteristics are, at least in part, the result of a complex equilibrium between DAF-16/FOXO, SKN-1, and HSF-1 factors. Moreover, we show that proteasome activation confers resistance to proteotoxic stress, thus nominating this complex as a potential candidate to minimize aggregation-related negative outcomes. This is the first report of proteostasis enhancement through 20S proteasome core activation that promotes longevity and stress/proteotoxic resistance in an intact multicellular organism.
E3 ligases are the first UPS components that have been modulated in multicellular organisms (35, 49–52). Their modulation has been shown to alter nematode life span and stress resistance through the selectively altered proteolysis of their target proteins. More recently, enhancement of 26S activity (but notably not content) has been achieved via overexpression of different 19S activator proteasome subunits in Drosophila (11) and in C. elegans (12), and the role of UBH-4 deubiquitinating enzyme on proteasome activity has been also revealed in C. elegans (53). In the current study, we have interfered with the last effector of the UPS system, the 20S proteasome, thus enhancing the general proteasome content and function. Our results indicate a common regulation between proteasome subunits because overexpression of pbs-5 has resulted in up-regulation of both β- and α-type subunits. A similar co-regulation at least between β-type subunits has been shown in human (8, 16, 54, 55) and murine (56) cells. These studies indicated β-type subunits as the “rate-limiting” factors for the determination of total 20S proteasome levels. Native gel electrophoresis reveals that there are more 20S and 26S proteasomes in pbs-5 OE animals. Consistent with enhanced 26S proteasome activity in our lines, we found decreased levels of polyubiquitinated proteins. These results support that proteasome up-regulation in terms of content, assembly, and function is feasible in a higher organism.
Proteasome activation confers increased life span and health span maintenance in wt animals, in agreement with previous studies in human fibroblasts (16) or yeast cells (57, 58). Animals overexpressing pbs-5 possess decreased levels of carbonylated proteins, suggesting a possible increased clearance by the proteasome. These diminished levels could also be linked to the enhanced longevity of wt pbs-5 OE animals. In support, previous studies revealed a negative correlation between protein carbonylation levels and life span, suggesting that high levels may contribute to a shortened life span in daf-16 mutants, and lower levels are found in long-lived age-1 and daf-2 mutants (59). These findings along with the observed lower rates of age pigments accumulation reveal a pivotal role of the proteasome on proteostasis and organismal life span.
Many manipulations that increase nematode longevity also increase resistance to various acute stressors. We also report a protective effect of proteasome activation against oxidative stress, in accordance with studies in mammalian (16, 55, 56) and yeast cells (57, 58). In support, animals with impaired UPS function present oxidative-mediated damage (60). We show that enhanced proteasome activity does not confer resistance to all kinds of stress, in accordance with previous reports (12). Concerning HS, proteasome activation does not seem to promote survival in accordance with a recent study showing that pbs-5 negatively regulates HSR (39). Although there are studies that challenge the link between oxidative damage accumulation and C. elegans longevity (61, 62), the possible deleterious effects of accumulated specific stress-damaged proteins due to dysfunctional proteasomal degradation cannot be ignored.
Metabolic signaling pathways that regulate the aging process, mediated by IIS (with the involvement of both DAF-16 and HSF-1 stress responsive factors) or SKN-1 (32, 33) can modulate the proteostasis machinery to maintain a youthful proteome for longer (5). Our results indicate that pbs-5–mediated life span extension is a complex trait among DAF-16/FOXO, SKN-1, and HSF-1 factors and, at least in part, the regulation of their downstream targets. Proteasome modulation through multiple trivial pathways associated with life span is apparently necessary to ensure an adequate cellular response during the aging progression and its effects in proteostasis. Nonetheless, our results also suggest that proteasome activation does not always exert beneficial effects on longevity. The genetic background dictates whether such enhancement will turn out to be beneficial, neutral, or even toxic. For example, in mutants like hsf-1 where proteostasis collapse is overwhelming, we do not observe a positive effect of proteasome activation. Moreover, HSF-1 is necessary during larval development for proteotoxicity protection (63), and it sets the needed conditions during early developmental stages that enable DAF-16 to promote longevity later on (64). Therefore, hypomorphic hsf-1 mutants are more aggravated (in terms of proteotoxic insults) compared with wt animals from the beginning of their lives and thus pbs-5 OE and its positive outcomes might not be enough to rescue this heavily problematic phenotype.
Finally, we show a PBS-5–mediated increased resistance to proteotoxic stress in AD and HD nematode models. Therefore, proteasome activation appears to be a potential protective player in the battle against disorders that are linked to proteostasis failure. We suggest that this is directly related to the proteasome-mediated proteolysis of toxic oligomers. In support, worms with decreased proteasome activity due to lack of an inducible 19S subunit are unable to combat proteotoxic insult (65), and overexpression of the same subunit reduces Aβ accumulation thus reducing β-amyloid peptide toxicity (66). Additionally, 26S proteasome activation has been shown to reduce aggregated polyQ proteins (12). In conclusion, the modulation of cellular degradation systems is an emerging field of potential therapeutic intervention in aggregation-related pathologies (67).
Aging is accompanied by the gradual accumulation of damaged macromolecules due to defects of both repair and elimination. Our results suggest that the enhancement of the core proteasome content and activity endows the organism with an elevated capacity of removing oxidized and misfolded/aggregated proteins, thus preserving proteostasis. As the current work demonstrates that genetically mediated core proteasome up-regulation and activation in a multicellular organism promotes longevity, future anti-aging studies should emphasize on the combined and highly balanced activation of the various UPS nodes.
Supplementary Material
Acknowledgments
The authors are grateful to Prof. Osiewacz and Dr. Zhang for antibodies; to Dr. Ninios, K. Voutetakis, and A. Pasparaki for technical support; and to Drs. Bano and Troulinaki for discussions and reagents. Nematode strains used in this study were provided by the Caenorhabditis Genetics Center, supported by the U.S. National Institutes of Health National Center for Research Resources. This work was funded by a European Union (“Proteomage”; LSHM-CT-518230) grant (to E.S.G.), a Research Funding Program: Thales “GenAge,” cofinanced by the European Union (European Social Fund) and Greek national funds through the Operational Program “Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) [ΘΑΛΗΣ ΑΠ:10479/3.7.12 MIS380228] (to E.S.G. and N.C.), and an IKYDA 2012 fellowship and a Scientific Project funded by John S. Latsis Public Benefit Foundation (to N.C.).
Glossary
- AD
Alzheimer’s disease
- CT-L
chymotrypsin-like
- DAF-16/FOXO
Dauer formation abnormal/Forkhead box class O
- DR
dietary restriction
- IIS
insulin/IGF-1 signaling
- HD
Huntington’s disease
- HS
heat stress
- HSF-1
heat shock factor-1
- HSR
heat shock response
- NRLB
nonreducing Laemmli buffer
- pbs-5 OE
pbs-5 overexpression
- RNAi
RNA interference
- SKN-1
skinhead-1
- UPS
ubiquitin-proteasome system
- wt
wild type
Footnotes
This article includes supplemental data. Please visit http://www.fasebj.org to obtain this information.
REFERENCES
- 1.Kirkwood T. B. L., Melov S. (2011) On the programmed/non-programmed nature of ageing within the life history. Curr. Biol. 21, R701–R707 [DOI] [PubMed] [Google Scholar]
- 2.Vijg J., Campisi J. (2008) Puzzles, promises and a cure for ageing. Nature 454, 1065–1071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chondrogianni N., Petropoulos I., Grimm S., Georgila K., Catalgol B., Friguet B., Grune T., Gonos E. S. (2014) Protein damage, repair and proteolysis. Mol. Aspects Med. 35, 1–71 [DOI] [PubMed] [Google Scholar]
- 4.López-Otín C., Blasco M. A., Partridge L., Serrano M., Kroemer G. (2013) The hallmarks of aging. Cell 153, 1194–1217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Taylor R. C., Dillin A. (2011) Aging as an event of proteostasis collapse. Cold Spring Harb. Perspect. Biol. 3, a004440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Weissman A. M., Shabek N., Ciechanover A. (2011) The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 12, 605–620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chondrogianni N., Petropoulos I., Franceschi C., Friguet B., Gonos E. S. (2000) Fibroblast cultures from healthy centenarians have an active proteasome. Exp. Gerontol. 35, 721–728 [DOI] [PubMed] [Google Scholar]
- 8.Chondrogianni N., Stratford F. L. L., Trougakos I. P., Friguet B., Rivett A. J., Gonos E. S. (2003) Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 278, 28026–28037 [DOI] [PubMed] [Google Scholar]
- 9.Chondrogianni N., Trougakos I. P., Kletsas D., Chen Q. M., Gonos E. S. (2008) Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status. Aging Cell 7, 717–732 [DOI] [PubMed] [Google Scholar]
- 10.Chondrogianni N., Gonos E. S. (2008) Proteasome activation as a novel antiaging strategy. IUBMB Life 60, 651–655 [DOI] [PubMed] [Google Scholar]
- 11.Tonoki A., Kuranaga E., Tomioka T., Hamazaki J., Murata S., Tanaka K., Miura M. (2009) Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process. Mol. Cell. Biol. 29, 1095–1106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Vilchez D., Morantte I., Liu Z., Douglas P. M., Merkwirth C., Rodrigues A. P. C., Manning G., Dillin A. (2012) RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature 489, 263–268 [DOI] [PubMed] [Google Scholar]
- 13.Hoogewijs D., Houthoofd K., Matthijssens F., Vandesompele J., Vanfleteren J. R. (2008) Selection and validation of a set of reliable reference genes for quantitative sod gene expression analysis in C. elegans. BMC Mol. Biol. 9, 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fraser A. G., Kamath R. S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J. (2000) Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325–330 [DOI] [PubMed] [Google Scholar]
- 15.Myeku N., Metcalfe M. J., Huang Q., Figueiredo-Pereira M. (2011) Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures. Methods Mol. Biol. 793, 273–296 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chondrogianni N., Tzavelas C., Pemberton A. J., Nezis I. P., Rivett A. J., Gonos E. S. (2005) Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates. J. Biol. Chem. 280, 11840–11850 [DOI] [PubMed] [Google Scholar]
- 17.Li X., Matilainen O., Jin C., Glover-Cutter K. M., Holmberg C. I., Blackwell T. K. (2011) Specific SKN-1/Nrf stress responses to perturbations in translation elongation and proteasome activity. PLoS Genet. 7, e1002119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wójcik C., DeMartino G. N. (2002) Analysis of Drosophila 26 S proteasome using RNA interference. J. Biol. Chem. 277, 6188–6197 [DOI] [PubMed] [Google Scholar]
- 19.Coburn C., Gems D. (2013) The mysterious case of the C. elegans gut granule: death fluorescence, anthranilic acid and the kynurenine pathway. Front. Genet. 4, 151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sánchez-Blanco A., Kim S. K. (2011) Variable pathogenicity determines individual lifespan in Caenorhabditis elegans. PLoS Genet. 7, e1002047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gerstbrein B., Stamatas G., Kollias N., Driscoll M. (2005) In vivo spectrofluorimetry reveals endogenous biomarkers that report healthspan and dietary restriction in Caenorhabditis elegans. Aging Cell 4, 127–137 [DOI] [PubMed] [Google Scholar]
- 22.Wilkinson D. S., Taylor R. C., Dillin A. (2012) Analysis of aging in Caenorhabditis elegans. Methods Cell Biol. 107, 353–381 [DOI] [PubMed] [Google Scholar]
- 23.Felkai S., Ewbank J. J., Lemieux J., Labbé J. C., Brown G. G., Hekimi S. (1999) CLK-1 controls respiration, behavior and aging in the nematode Caenorhabditis elegans. EMBO J. 18, 1783–1792 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Riddle D. L., Swanson M. M., Albert P. S. (1981) Interacting genes in nematode dauer larva formation. Nature 290, 668–671 [DOI] [PubMed] [Google Scholar]
- 25.Kenyon C. (2005) The plasticity of aging: insights from long-lived mutants. Cell 120, 449–460 [DOI] [PubMed] [Google Scholar]
- 26.Libina N., Berman J. R., Kenyon C. (2003) Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115, 489–502 [DOI] [PubMed] [Google Scholar]
- 27.Lee S. S., Kennedy S., Tolonen A. C., Ruvkun G. (2003) DAF-16 target genes that control C. elegans life-span and metabolism. Science 300, 644–647 [DOI] [PubMed] [Google Scholar]
- 28.Murphy C. T., McCarroll S. A., Bargmann C. I., Fraser A., Kamath R. S., Ahringer J., Li H., Kenyon C. (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277–283 [DOI] [PubMed] [Google Scholar]
- 29.Li J., Ebata A., Dong Y., Rizki G., Iwata T., Lee S. S. (2008) Caenorhabditis elegans HCF-1 functions in longevity maintenance as a DAF-16 regulator. PLoS Biol. 6, e233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Alam H., Williams T. W., Dumas K. J., Guo C., Yoshina S., Mitani S., Hu P. J. (2010) EAK-7 controls development and life span by regulating nuclear DAF-16/FoxO activity. Cell Metab. 12, 30–41 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wolff S., Ma H., Burch D., Maciel G. A., Hunter T., Dillin A. (2006) SMK-1, an essential regulator of DAF-16-mediated longevity. Cell 124, 1039–1053 [DOI] [PubMed] [Google Scholar]
- 32.Bishop N. A., Guarente L. (2007) Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 447, 545–549 [DOI] [PubMed] [Google Scholar]
- 33.Tullet J. M., Hertweck M., An J. H., Baker J., Hwang J. Y., Liu S., Oliveira R. P., Baumeister R., Blackwell T. K. (2008) Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132, 1025–1038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kahn N. W., Rea S. L., Moyle S., Kell A., Johnson T. E. (2008) Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans. Biochem. J. 409, 205–213 [DOI] [PubMed] [Google Scholar]
- 35.Choe K. P., Przybysz A. J., Strange K. (2009) The WD40 repeat protein WDR-23 functions with the CUL4/DDB1 ubiquitin ligase to regulate nuclear abundance and activity of SKN-1 in Caenorhabditis elegans. Mol. Cell. Biol. 29, 2704–2715 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Oliveira R. P., Porter Abate J., Dilks K., Landis J., Ashraf J., Murphy C. T., Blackwell T. K. (2009) Condition-adapted stress and longevity gene regulation by Caenorhabditis elegans SKN-1/Nrf. Aging Cell 8, 524–541 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ben-Zvi A., Miller E. A., Morimoto R. I. (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc. Natl. Acad. Sci. USA 106, 14914–14919 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bennett E. J., Bence N. F., Jayakumar R., Kopito R. R. (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17, 351–365 [DOI] [PubMed] [Google Scholar]
- 39.Guisbert E., Czyz D. M., Richter K., McMullen P. D., Morimoto R. I. (2013) Identification of a tissue-selective heat shock response regulatory network. PLoS Genet. 9, e1003466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Grune T., Merker K., Sandig G., Davies K. J. A. (2003) Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem. Biophys. Res. Commun. 305, 709–718 [DOI] [PubMed] [Google Scholar]
- 41.Grune T., Reinheckel T., Davies K. J. (1997) Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526–534 [PubMed] [Google Scholar]
- 42.Pickering A. M., Davies K. J. A. (2012) Degradation of damaged proteins: the main function of the 20S proteasome. Prog. Mol. Biol. Transl. Sci. 109, 227–248 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Layfield R., Cavey J. R., Lowe J. (2003) Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders. Ageing Res. Rev. 2, 343–356 [DOI] [PubMed] [Google Scholar]
- 44.Paul S. (2008) Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. BioEssays 30, 1172–1184 [DOI] [PubMed] [Google Scholar]
- 45.Morley J. F., Brignull H. R., Weyers J. J., Morimoto R. I. (2002) The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 99, 10417–10422 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Brignull H. R., Moore F. E., Tang S. J., Morimoto R. I. (2006) Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J. Neurosci. 26, 7597–7606 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Link C. D., Taft A., Kapulkin V., Duke K., Kim S., Fei Q., Wood D. E., Sahagan B. G. (2003) Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer’s disease model. Neurobiol. Aging 24, 397–413 [DOI] [PubMed] [Google Scholar]
- 48.Wu Y., Wu Z., Butko P., Christen Y., Lambert M. P., Klein W. L., Link C. D., Luo Y. (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J. Neurosci. 26, 13102–13113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Carrano A. C., Liu Z., Dillin A., Hunter T. (2009) A conserved ubiquitination pathway determines longevity in response to diet restriction. Nature 460, 396–399 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ghazi A., Henis-Korenblit S., Kenyon C. (2007) Regulation of Caenorhabditis elegans lifespan by a proteasomal E3 ligase complex. Proc. Natl. Acad. Sci. USA 104, 5947–5952 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Li W., Gao B., Lee S.-M., Bennett K., Fang D. (2007) RLE-1, an E3 ubiquitin ligase, regulates C. elegans aging by catalyzing DAF-16 polyubiquitination. Dev. Cell 12, 235–246 [DOI] [PubMed] [Google Scholar]
- 52.Mehta R., Steinkraus K. A., Sutphin G. L., Ramos F. J., Shamieh L. S., Huh A., Davis C., Chandler-Brown D., Kaeberlein M. (2009) Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 324, 1196–1198 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Matilainen O., Arpalahti L., Rantanen V., Hautaniemi S., Holmberg C. I. (2013) Insulin/IGF-1 signaling regulates proteasome activity through the deubiquitinating enzyme UBH-4. Cell Reports 3, 1980–1995 [DOI] [PubMed] [Google Scholar]
- 54.Gaczynska M., Goldberg A. L., Tanaka K., Hendil K. B., Rock K. L. (1996) Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7. J. Biol. Chem. 271, 17275–17280 [DOI] [PubMed] [Google Scholar]
- 55.Liu Y., Liu X., Zhang T., Luna C., Liton P. B., Gonzalez P. (2007) Cytoprotective effects of proteasome beta5 subunit overexpression in lens epithelial cells. Mol. Vis. 13, 31–38 [PMC free article] [PubMed] [Google Scholar]
- 56.Kwak M.-K., Cho J.-M., Huang B., Shin S., Kensler T. W. (2007) Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic. Biol. Med. 43, 809–817 [DOI] [PubMed] [Google Scholar]
- 57.Chen Q., Thorpe J., Dohmen J. R., Li F., Keller J. N. (2006) Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome? Free Radic. Biol. Med. 40, 120–126 [DOI] [PubMed] [Google Scholar]
- 58.Kruegel U., Robison B., Dange T., Kahlert G., Delaney J. R., Kotireddy S., Tsuchiya M., Tsuchiyama S., Murakami C. J., Schleit J., Sutphin G., Carr D., Tar K., Dittmar G., Kaeberlein M., Kennedy B. K., Schmidt M. (2011) Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLoS Genet. 7, e1002253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Yasuda K., Adachi H., Fujiwara Y., Ishii N. (1999) Protein carbonyl accumulation in aging dauer formation-defective (daf) mutants of Caenorhabditis elegans. J. Gerontol. A Biol. Sci. Med. Sci. 54, B47–B51, discussion B52–B53 [DOI] [PubMed] [Google Scholar]
- 60.Liu G., Rogers J., Murphy C. T., Rongo C. (2011) EGF signalling activates the ubiquitin proteasome system to modulate C. elegans lifespan. EMBO J. 30, 2990–3003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Doonan R., McElwee J. J., Matthijssens F., Walker G. A., Houthoofd K., Back P., Matscheski A., Vanfleteren J. R., Gems D. (2008) Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 22, 3236–3241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Van Raamsdonk J. M., Hekimi S. (2009) Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet. 5, e1000361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Cohen E., Du D., Joyce D., Kapernick E. A., Volovik Y., Kelly J. W., Dillin A. (2010) Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection. Aging Cell 9, 126–134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Volovik Y., Maman M., Dubnikov T., Bejerano-Sagie M., Joyce D., Kapernick E. A., Cohen E., Dillin A. (2012) Temporal requirements of heat shock factor-1 for longevity assurance. Aging Cell 11, 491–499 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Yun C., Stanhill A., Yang Y., Zhang Y., Haynes C. M., Xu C.-F., Neubert T. A., Mor A., Philips M. R., Ron D. (2008) Proteasomal adaptation to environmental stress links resistance to proteotoxicity with longevity in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 105, 7094–7099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hassan W. M., Merin D. A., Fonte V., Link C. D. (2009) AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer’s disease model. Hum. Mol. Genet. 18, 2739–2747 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Huang Q., Figueiredo-Pereira M. E. (2010) Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15, 1292–1311 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.